Efficacy and Tolerability of Fesoterodine for Overactive Bladder Syndrome in Children: an Extension Study.

Trial Profile

Efficacy and Tolerability of Fesoterodine for Overactive Bladder Syndrome in Children: an Extension Study.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Fesoterodine (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Nov 2016 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
    • 27 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Oct 2017.
    • 27 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top